Psychedelic research is underway at the University of Aalborg after serving as a test site for COMPASS Pathways.
University Hospital Aalborg served as a test site for COMPASS Pathways and their study investigating the effects of COMP360 (psilocybin) in patients with treatment-resistant depression. Professor of Psychiatry and Head of Psychiatry Research, Rasmus Licht, oversaw this arm of the large-scale international study.
Activities
Research Institute
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates